BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 23419223)

  • 21. Does the presence of an open-label antidepressant treatment period influence study outcome in clinical trials examining augmentation/combination strategies in treatment partial responders/nonresponders with major depressive disorder?
    Iovieno N; Papakostas GI
    J Clin Psychiatry; 2012 May; 73(5):676-83. PubMed ID: 22569112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does co-morbid depression impact diabetes related costs? Evidence from a cross-sectional survey in a low-income country.
    Chereches RM; Litan CM; Zlati AM; Bloom JR
    J Ment Health Policy Econ; 2012 Sep; 15(3):127-38. PubMed ID: 23001281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atherosclerosis and incident depression in late life.
    Newson RS; Hek K; Luijendijk HJ; Hofman A; Witteman JC; Tiemeier H
    Arch Gen Psychiatry; 2010 Nov; 67(11):1144-51. PubMed ID: 21041615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Limbic-hypothalamic-pituitary-adrenal axis in depression: literature review].
    Twardowska K; Rybakowski J
    Psychiatr Pol; 1996; 30(5):741-55. PubMed ID: 8984515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis.
    Iovieno N; Papakostas GI
    J Clin Psychiatry; 2012 Oct; 73(10):1300-6. PubMed ID: 23140647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalent depressive symptoms as a risk factor for conversion to mild cognitive impairment in an elderly Italian cohort.
    Ravaglia G; Forti P; Lucicesare A; Rietti E; Pisacane N; Mariani E; Dalmonte E
    Am J Geriatr Psychiatry; 2008 Oct; 16(10):834-43. PubMed ID: 18827230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The neurobiological basis of mixed depression-anxiety states.
    Gulley LR; Nemeroff CB
    J Clin Psychiatry; 1993 Jan; 54 Suppl():16-9. PubMed ID: 8093884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sponsorship, antidepressant dose, and outcome in major depressive disorder: meta-analysis of randomized controlled trials.
    Sinyor M; Schaffer A; Smart KA; Levitt AJ; Lanctôt KL; Grysman NH
    J Clin Psychiatry; 2012 Feb; 73(2):e277-87. PubMed ID: 22401489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrovascular risk factors and incident depression in community-dwelling elderly.
    Luijendijk HJ; Stricker BH; Hofman A; Witteman JC; Tiemeier H
    Acta Psychiatr Scand; 2008 Aug; 118(2):139-48. PubMed ID: 18452572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Confounding by severity and indication in observational studies of antidepressant effectiveness.
    Patten SB
    Can J Clin Pharmacol; 2008; 15(2):e367-71. PubMed ID: 18840922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of depression in ambulatory care for patients with medical co-morbidities: a study from a national Electronic Health Record (EHR) network.
    Gill JM; Chen YX; Lieberman MI
    Int J Psychiatry Med; 2008; 38(2):203-15. PubMed ID: 18724571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analyses indicate associations between neuroendocrine activation, deactivation in neurotrophic and neuroimaging markers in depression after stroke.
    Noonan K; Carey LM; Crewther SG
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e124-35. PubMed ID: 23149149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age and risk for depression among the elderly: a meta-analysis of the published literature.
    Zhao KX; Huang CQ; Xiao Q; Gao Y; Liu QX; Wang ZR; Li YH; Xie YZ
    CNS Spectr; 2012 Sep; 17(3):142-54. PubMed ID: 22892113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depressive disorder and incident diabetes mellitus: the effect of characteristics of depression.
    Campayo A; de Jonge P; Roy JF; Saz P; de la Cámara C; Quintanilla MA; Marcos G; Santabárbara J; Lobo A;
    Am J Psychiatry; 2010 May; 167(5):580-8. PubMed ID: 20123914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis.
    Hiles SA; Baker AL; de Malmanche T; Attia J
    Psychol Med; 2012 Oct; 42(10):2015-26. PubMed ID: 22336436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ischemic heart disease and depression: an underestimated clinical association].
    Pizzi C; Santarella L; Manfrini O; Chiavaroli M; Agushi E; Cordioli E; Costa GM; Bugiardini R
    G Ital Cardiol (Rome); 2013; 14(7-8):526-37. PubMed ID: 23877550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of depression with pre-diabetes, undiagnosed diabetes, and previously diagnosed diabetes: a meta-analysis.
    Chen S; Zhang Q; Dai G; Hu J; Zhu C; Su L; Wu X
    Endocrine; 2016 Jul; 53(1):35-46. PubMed ID: 26832340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health status and risk for depression among the elderly: a meta-analysis of published literature.
    Chang-Quan H; Xue-Mei Z; Bi-Rong D; Zhen-Chan L; Ji-Rong Y; Qing-Xiu L
    Age Ageing; 2010 Jan; 39(1):23-30. PubMed ID: 19903775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comorbidity of diabetes mellitus and depression in the general population in Germany].
    Maske UE; Scheidt-Nave C; Busch MA; Jacobi F; Weikert B; Riedel-Heller SG; Hapke U
    Psychiatr Prax; 2015 May; 42(4):202-7. PubMed ID: 24858432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding depression in palliative and end-of-life care.
    Taylor V; Ashelford S
    Nurs Stand; 2008 Nov 26-Dec 2; 23(12):48-57; quiz 58, 60. PubMed ID: 19093358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.